FinTrust Investment Advisory Services’s GSK GSK Stock Holding History

FinTrust Investment Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$248K	Sell	5,072 -1,402	-22%	-$65.3K	0.23%	90
2017 Q4	$287K	Sell	6,474 -1,418	-18%	-$65.5K	0.25%	84
2017 Q3	$401K	Buy	+7,892	New	+$400K	0.38%	59

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FinTrust Investment Advisory Services's GSK Position: Q1 2018 in Review

FinTrust Investment Advisory Services reduced its GSK (GSK) stake by 22% in Q1 2018, selling an estimated $65.3K and leaving 5,072 shares worth $248K. The position accounts for 0.23% of the portfolio, ranked #90.

FinTrust Investment Advisory Services first reported a position in GSK in Q3 2017 and has held it in 3 quarters since. The position peaked at $401K in Q3 2017. 779 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

FinTrust Investment Advisory Services held 5,072 shares of GSK worth $248K as of Q1 2018.
FinTrust Investment Advisory Services sold 1,402 GSK shares in Q1 2018, an estimated $65.3K.
GSK made up 0.23% of FinTrust Investment Advisory Services's portfolio in Q1 2018, its #90 holding.
FinTrust Investment Advisory Services first reported a position in GSK in Q3 2017 and has held it in 3 quarters since.
FinTrust Investment Advisory Services's GSK position peaked at $401K in Q3 2017.
779 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on FinTrust Investment Advisory Services's 13F filing for Q1 2018, filed 20 Apr 2018.